Dolutegravir (DTG) use during pregnancy and birth outcomes: data from the Antiretroviral Pregnancy Registry (APR)

被引：0

作者：

Vannappagari, V. ^{[1
,2
]}

Albano, J. ^{[3
]}

Ragone, L. ^{[1
]}

Cook, T. ^{[3
]}

Scheuerle, A. ^{[4
]}

Short, W. ^{[5
]}

Thorne, C. ^{[6
]}

Beckerman, K. ^{[7
]}

Tilson, H. ^{[2
]}

Chakhtoura, N. ^{[8
]}

Watts, D. H. ^{[9
]}

Mofenson, L. ^{[10
]}

机构：

[1] ViiV Healthcare Epidemiol & Real World Evidence, Res Triangle Pk, NC USA

[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

[3] Syneos Hlth, Wilmington, NC USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[6] UCL, Great Ormond St Inst Child Hlth, London, England

[7] BronxCare Hlth Syst, Carl Icahn Sch Med Mt Sinai, Bronx, NY USA

[8] Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD USA

[9] Global AIDS Coordinator & Hlth Diplomacy, Washington, DC USA

[10] Elizabeth Glaser Pediat AIDS Fdn, Silver Spring, MD USA

来源：

HIV MEDICINE | 2019年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

PS1/2

引用

页码：3 / 4

页数：2

共 50 条

[41] Use of opioids during pregnancy and effects of pregnancy outcomes
Faltmarch, Stella
Perttila, Iiro
Tuomi, Ulla
Kautiainen, Hannu
Gissler, Mika
Pennanen, Pirjo
Eriksson, Johan G.
Laine, Merja K.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (09) : 1239 - 1245
[42] Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data
Prestes-Carneiro, Luiz Euribel
HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2013, 5 : 181 - 189
[43] Central nervous system birth defects and antiretroviral use in pregnancy
Beckerman, K. P.
Covington, D.
Clax, P.
Martinez-Tristani, M.
Seekins, D.
Scheuerle, A.
Watts, D. H.
Tilson, H.
PROCEEDINGS OF THE 8TH WORLD CONGRESS OF PERINATAL MEDICINE, 2007, : 327 - 331
[44] Hepatitis B Virus (HBV) Drugs in Pregnancy: Findings from the Antiretroviral Pregnancy Registry
Brown, Robert S.
Buti, Maria
Goodwin, Diane
Zhang, Sherry
Fagan, Elizabeth A.
GASTROENTEROLOGY, 2009, 136 (05) : A798 - A798
[45] HEPATITIS B VIRUS (HBV) DRUGS IN PREGNANCY: FINDINGS FROM THE ANTIRETROVIRAL PREGNANCY REGISTRY
Brown, R. S., Jr.
Buti, M.
Goodwin, D.
Zhang, S.
Fagan, E.
JOURNAL OF HEPATOLOGY, 2009, 50 : S4 - S4
[46] Hepatitis B virus (HBV) drugs in pregnancy: findings from the antiretroviral pregnancy registry
Elsome, A. M.
Brown, R. S., Jr.
Goodwin, D.
Zhang, S.
Fagan, E.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A286 - A286
[47] The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy
Namazy, Jennifer
Cabana, Michael D.
Scheuerle, Angela E.
Thorp, John M., Jr.
Chen, Hubert
Carrigan, Gillis
Wang, Yan
Veith, Joachim
Andrews, Elizabeth B.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : 407 - 412
[48] Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry
Juliao, Patricia
Wurst, Keele
Pimenta, Jeanne M.
Gemzoe, Kim
Landy, Helain
Moody, M. Anthony
Tilson, Hugh
Covington, Deborah
Moore, Tammy
Marino, Rebecca
Gilbride, Jennifer
Liu, Andrew
Meizlik, Paige
Petri, Michelle
BIRTH DEFECTS RESEARCH, 2023, 115 (02): : 188 - 204
[49] The effect of incarceration during pregnancy on birth outcomes
Martin, SL
Rieger, RH
Kupper, LL
Meyer, RE
Qaqish, BF
PUBLIC HEALTH REPORTS, 1997, 112 (04) : 340 - 346
[50] Risk of birth defects associated with antiretroviral exposure during pregnancy
Beckerman, K
Covington, D
Watts, H
Tilson, H
Chavers, S
Sacks, S
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (06) : S60 - S60

← 1 2 3 4 5 →